BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-645@pharmaconomics
DTSTAMP:20260707T052551Z
DTSTART;VALUE=DATE:20260504
DTEND;VALUE=DATE:20260505
SUMMARY:ADMA Approval — ASCENIV
DESCRIPTION:A final FDA approval decision on ASCENIV for primary humoral immunodeficiency (PI) is expected May 4\, 2026.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1368514/000114036126018667/ef20072196_ex99-1.htm\n\nTrack it: https://pharmaconomics.com/e/645
URL:https://pharmaconomics.com/e/645
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:ADMA catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR